Plain-English translation of NCT05102110 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are investigating whether collecting a small sample of rectal mucus can help identify cancer cells from several different cancer types, including lung, pancreatic, bladder, and colorectal cancers. The study is testing whether this quick, non-invasive sampling method could become a useful tool to help doctors detect cancers earlier or monitor them over time. This approach is being studied because it's simple, can be repeated easily, and doesn't require invasive procedures like endoscopy.
During the COVID-19 pandemic, many cancer screening procedures like endoscopy were postponed or delayed, highlighting the need for simpler, non-invasive ways to detect cancer. Researchers believe that cancer cells shed into the digestive tract could potentially be detected through a rectal mucus sample, offering a faster, easier screening option that doctors in primary care could use to help decide who needs more advanced testing.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would visit the research site where a trained healthcare provider would collect a small sample of rectal mucus—a quick, minimally invasive procedure similar to a routine rectal exam. Your sample would then be analyzed for genetic markers that might indicate cancer. The study is designed to understand whether this sampling method can reliably detect cancer signals and could eventually help doctors screen for or monitor these cancers.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United Kingdom